Blueprint Medicines Corp (BPMC)
35.41 x 2 141.61 x 2
Post-market by (Cboe BZX)
88.51 +0.85 (+0.97%) 04/28/25 [NASDAQ]
35.41 x 2 141.61 x 2
Post-market 89.50 +0.99 (+1.12%) 17:44 ET
for Mon, Apr 28th, 2025
Try Excel 
Watch
-
Add or delete the symbol from one or more Watchlists.
-
Create New Watchlist
This name already in use.
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -67,089 | -506,984 | -557,517 | -644,085 | 313,882 |
| Depreciation Amortization | -6,174 | -5,801 | 10,753 | 7,840 | 7,025 |
| Accounts receivable | -32,698 | -7,654 | -2,232 | -11,805 | -1,851 |
| Accounts payable and accrued liabilities | 2,197 | 1,880 | -5,816 | 4,221 | -791 |
| Other Working Capital | -64,685 | -41,128 | -53,769 | -23,680 | -15,618 |
| Other Operating Activity | -24,137 | 122,840 | 106,304 | 368,856 | 84,388 |
| Operating Cash Flow | $-192,586 | $-436,847 | $-502,277 | $-298,653 | $387,035 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -42,871 | 290,102 | -140,332 | 35,381 | -431,090 |
| PPE Investments | -4,630 | -16,062 | -8,919 | -3,089 | -3,159 |
| Purchase Sale Intangibles | N/A | N/A | N/A | -258,152 | N/A |
| Other Investing Activity | 0 | 0 | -290 | -258,152 | 0 |
| Investing Cash Flow | $-47,501 | $274,040 | $-149,541 | $-225,860 | $-434,249 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 146,973 | 97,933 | 553,614 | N/A | N/A |
| Debt Repayment | -541 | -44 | N/A | N/A | N/A |
| Common Stock Issued | 77,743 | 21,336 | 8,196 | 50,716 | 617,759 |
| Other Financing Activity | 48,936 | 0 | 0 | 0 | 0 |
| Financing Cash Flow | $273,111 | $119,225 | $561,810 | $50,716 | $617,759 |
| Exchange Rate Effect | -909 | 202 | -207 | -888 | -345 |
| Beginning Cash Position | 81,524 | 124,904 | 215,119 | 689,804 | 119,604 |
| End Cash Position | 113,639 | 81,524 | 124,904 | 215,119 | 689,804 |
| Net Cash Flow | $32,115 | $-43,380 | $-90,215 | $-474,685 | $570,200 |
| Free Cash Flow | |||||
| Operating Cash Flow | -192,586 | -436,847 | -502,277 | -298,653 | 387,035 |
| Capital Expenditure | -4,630 | -16,062 | -8,919 | -3,089 | -3,159 |
| Free Cash Flow | -197,216 | -452,909 | -511,196 | -301,742 | 383,876 |